Toby notes Lilly posted $22.97 billion in Q2 2026 revenue, up 46% in a year, driven by one molecule sold under two brand names.
Recap by typeshit. Post by Toby on X.
The Darling Ingredients unit says the supplement ingredient concentrates over ten neurosupportive peptides, with clinical trials planned to start in December.
The plastic surgeon weighs in on semaglutide and other GLP-1 drugs as more patients of every age turn to them for major weight loss.
Traders Union looks at whether Novo Nordisk shares can hold their gains, pointing to the Wegovy pill approval and recent trial data.
The actor says GLP-1 drugs can make sense with a doctor's advice, but in his view no drug can stand in for working out.
In a small 2022 trial, whey beat leucine-boosted collagen for muscle growth, while evidence that collagen prevents sports injuries is still missing.
Mounjaro became India's top-selling drug in 2025, and a Scroll investigation reports that pharmacies are handing it out without the prescription it requires.
Loading…